Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study).
Lessard D, Engler K, Ma Y, Rodriguez Cruz A, Vicente S; Opal-COVID-19 Patient Expert Committee; Kronfli N, Barkati S, Brouillette MJ, Cox J, Kildea J, Hijal T, Pomey MP, Bartlett SJ, Asselah J, Lebouché B. Lessard D, et al. Among authors: brouillette mj. JMIR Res Protoc. 2022 Aug 18;11(8):e35760. doi: 10.2196/35760. JMIR Res Protoc. 2022. PMID: 35820054 Free PMC article.
Machine Learning Approaches to Understand Cognitive Phenotypes in People With HIV.
Mukerji SS, Petersen KJ, Pohl KM, Dastgheyb RM, Fox HS, Bilder RM, Brouillette MJ, Gross AL, Scott-Sheldon LAJ, Paul RH, Gabuzda D. Mukerji SS, et al. Among authors: brouillette mj. J Infect Dis. 2023 Mar 17;227(Suppl 1):S48-S57. doi: 10.1093/infdis/jiac293. J Infect Dis. 2023. PMID: 36930638 Free PMC article.
The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
Lebouché B, Jenabian MA, Singer J, Graziani GM, Engler K, Trottier B, Thomas R, Brouillette MJ, Routy JP. Lebouché B, et al. Among authors: brouillette mj. Trials. 2014 Oct 7;15:390. doi: 10.1186/1745-6215-15-390. Trials. 2014. PMID: 25293882 Free PMC article. Clinical Trial.
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.
Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA. Costiniuk CT, et al. Among authors: brouillette mj. BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793. BMJ Open. 2019. PMID: 30659041 Free PMC article.
Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education.
Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, Abdallah SJ, Jensen D, Lebouché B, Brouillette MJ, Klein M, Szabo J, Frenette C, Giannakis A, Jenabian MA. Costiniuk CT, et al. Among authors: brouillette mj. Cannabis Cannabinoid Res. 2019 Sep 23;4(3):204-213. doi: 10.1089/can.2018.0068. eCollection 2019. Cannabis Cannabinoid Res. 2019. PMID: 31579835 Free PMC article.
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy.
Lebouché B, Yero A, Shi T, Farnos O, Singer J, Kema I, Costiniuk CT, Thomas R, Brouillette MJ, Engler K, Routy JP, Jenabian MA; CTN PT006 Study Group. Lebouché B, et al. Among authors: brouillette mj. HIV Res Clin Pract. 2020 Dec;21(6):182-190. doi: 10.1080/25787489.2020.1866846. Epub 2021 Jan 6. HIV Res Clin Pract. 2020. PMID: 33403940 Clinical Trial.
Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic.
Fehr D, Lebouché B, Ruppenthal L, Brownc M, Obasc N, Bourbonnière E, Girouard J, Massicotte A, Jenabian MA, Almomen AA, Frenette C, de Pokomandy A, Cox J, Giannakis A, Cheng M, Kronfli N, Tsoukas C, Zahedi N, Szabo J, Dehghani K, Brouillette MJ, Falutz J, Turner H, Hamel A, Duchesneau C, Lanthier-Brun J, Klein M, Routy JP, Costiniuk CT. Fehr D, et al. Among authors: brouillette mj. AIDS Care. 2022 May;34(5):663-669. doi: 10.1080/09540121.2021.1904500. Epub 2021 Mar 28. AIDS Care. 2022. PMID: 33779425
Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028).
Mboumba Bouassa RS, Needham J, Nohynek D, Singer J, Lee T, Bobeuf F, Samarani S, Del Balso L, Paisible N, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Klein M, Lebouché B, Cox J, Brouillette MJ, Routy JP, Szabo J, Thomas R, Huchet E, Vigano A, Jenabian MA, Costiniuk CT. Mboumba Bouassa RS, et al. Among authors: brouillette mj. Biomedicines. 2022 Dec 7;10(12):3168. doi: 10.3390/biomedicines10123168. Biomedicines. 2022. PMID: 36551926 Free PMC article.
93 results